Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.

International journal of oncology - 1 Feb 2005

Mikysková Romana, Bubeník Jan, Vonka Vladimír, Smahel Michal, Indrova Marie, Bieblová Jana, Símová Jana, Jandlová Tána

Abstract excerpt

Malignant transformation of somatic cells followed by selection of the transformed cell populations can give rise to tumours that display an immune escape phenotype, MHC class I deficient neoplasms. Experiments were designed to examine whether the immune escape phenotype of HPV16-associated tumours is stable or whether the MHC class I expression can change during tumour progression and therapy. It has been found...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coculture Techniques
Share to Genes, MHC Class I

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Interferon-gamma

Share to Neoplasms, Experimental

Share to Oncogene Proteins, Viral

Share to Spleen

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 15645139

Genes

MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.PMID 15645139Read ↗

Tumour immunology, vaccination and escape strategies.Semantic proximity Read ↗

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to ImmunotherapySemantic proximity Read ↗

Tumour MHC class I downregulation and immunotherapy (Review).Semantic proximity Read ↗

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.Semantic proximity Read ↗

Cancer immune escape: MHC expression in primary tumours versus metastasesSemantic proximity Read ↗

Targeting HLA class I expression to increase tumor immunogenicitySemantic proximity Read ↗

B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer.Semantic proximity Read ↗

The biological consequences of altered MHC class I expression in tumours.Semantic proximity Read ↗

Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell CarcinomaSemantic proximity Read ↗

Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell CarcinomaSemantic proximity Read ↗

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.Semantic proximity Read ↗

IFNγ-dependent remodelling of the myeloid landscape underlies control of IFNγ-insensitive tumoursSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.